Evaluation of P57, P53 and Ki67 Expression in Meningiomas |
Kucukosmanoglu, Ilknur
(Department of Pathology, Konya City Hospital)
Karanis, Meryem Ilkay Eren (Department of Pathology, Konya City Hospital) Unlu, Yasar (Department of Pathology, Konya City Hospital) Coven, Ilker (Department of Neurosurgery, Konya City Hospital) |
1 | Csonka T, Murnyak B, Szepesi R, Bencze J, Bognar L, Klekner A, et al. : Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence. Folia Neuropathol 54 : 114-126, 2016 |
2 | Yang SY, Park CK, Park SH, Kim DG, Chung YS, Jung HW : Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry 79 : 574-580, 2008 DOI |
3 | De Carvalho GTC, Da Silva-Martins WC, De Magalhaes KCSF, Nunes CB, Soares AN, Tafuri LSA, et al. : Recurrence/regrowth in grade I meningioma: how to predict? Front Oncol 10 : 1144, 2020 DOI |
4 | Mehidine H, Refregiers M, Jamme F, Varlet P, Juchaux M, Devaux B, et al. : Molecular changes tracking through multiscale fluorescence microscopy differentiate meningioma grades and non-tumoral brain tissues. Sci Rep 11 : 3816, 2021 DOI |
5 | Lam WW, Hatada I, Ohishi S, Mukai T, Joyce JA, Cole TR, et al. : Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic beckwith-wiedemann syndrome (BWS) provides a novel genotypephenotype correlation. J Med Genet 36 : 518-523, 1999 DOI |
6 | Latic D, Pejic S, Savic S, Loncar Z, M Nikolic I, Nikolic G, et al. : Cyclin D1 and p57 expression in relation to clinicopathological characteristics and overall survival in patients with renal cell carcinoma. J BUON 24 : 301-309, 2019 |
7 | Madhuri TK, Tailor A, Haagsma B, Coley H, Butler-Manuel S : Relevance of immunohistochemical expression of p57kip2 in epithelial ovarian carcinoma- a systematic literature review. J Ovarian Res 5 : 46, 2012 DOI |
8 | Pecina-Slaus N, Kafka A, Vladusic T, Tomas D, Logara M, Skoko J, et al. : Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression. Int J Exp Pathol 97 : 159-169, 2016 DOI |
9 | Rossi MN, Antonangeli F : Cellular response upon stress: p57 contribution to the final outcome. Mediators Inflamm 2015 : 259325, 2015 DOI |
10 | Tesio M, Trumpp A : Breaking the cell cycle of HSCs by p57 and friends. Cell Stem Cell 9 : 187-192, 2011 DOI |
11 | Abry E, Thomassen IO, Salvesen OO, Torp SH : The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study. Pathol Res Pract 206 : 810-815, 2010 DOI |
12 | Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK, et al. : The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131 : 803-820, 2016 DOI |
13 | Pavelin S, Becic K, Forempoher G, Mrklic I, Pogorelic Z, Titlic M, et al. : Expression of Ki-67 and p53 in meningiomas. Neoplasma 60 : 480-485, 2013 DOI |
14 | Telugu RB, Chowhan AK, Rukmangadha N, Patnayak R, Phaneendra BV, Prasad BC, et al. : Histopathological and immunohistochemical evaluation of meningiomas with reference to proliferative markers p53 and Ki67. J Clin Diagn Res 10 : EC15-EC19, 2016 |
15 | Zhang X : Expression, correlation and prognostic significance of CD133, P57 and HSF1 in meningioma. Eur Rev Med Pharmacol Sci 21 : 4600-4605, 2017 |
16 | Cho H, Ha SY, Park SH, Park K, Chae YS : Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas. J Korean Med Sci 14 : 199-205, 1999 DOI |
17 | Kumar S, Kakkar A, Suri V, Kumar A, Bhagat U, Sharma MC, et al. : Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: adjuncts to histopathological grading and predictors of aggressive behavior. Neurol India 62 : 376-382, 2014 DOI |